The forecast for the import of heterocyclic compounds with N-hetero-atom(s) only into the US from 2024 to 2028 shows a consistent decline in volume. From 16.135 million kg in 2024, imports are expected to fall to just 3.9246 million kg by 2028. This represents a steady decrease, with an average annual reduction of approximately 24% over the five-year period. In 2023, actual imports stood at significantly higher levels, indicating a stark downtrend beginning in 2024.
Future trends to watch include potential regulatory changes, innovations in synthetic chemistry, and shifts in the global pharmaceutical supply chain. These factors might alter the demand and sourcing strategies for such compounds, further impacting import volumes to the US.
